Offer - Urjas Oil for just ₹ 1
Cancigin 50 Injection is a prescription medicine that is available as a Injection. Primarily, it is used for the treatment of Fungal Infections, Candidal Infection. Cancigin 50 Injection also has some secondary and off-label uses. These are listed below.
The optimal dosage of Cancigin 50 Injection is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
While these are the most often observed Cancigin 50 Injection side effects, there are can be others also. These have been listed below. Such side effects of Cancigin 50 Injection normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
Cancigin 50 Injection's effect during pregnancy is Moderate and Moderate while nursing. In addition, Cancigin 50 Injection's effects on the liver, heart and kidney are discussed below in the Cancigin 50 Injection related warnings section.
Other conditions have been mentioned below in the Cancigin 50 Injection contraindications section.
Additionally, Cancigin 50 Injection may also adversely react with other medicines. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Cancigin 50 Injection is considered not safe while driving, and is not addictive.
Cancigin 50 Injection is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
| Infant (1 month to 2 years) |
|
| Neonates (0 to 1 month) |
|
Is the use of Cancigin 50 Injection safe for pregnant women?
Pregnant women may experience moderate side effects from Cancigin. It is best to stop taking Cancigin immediately and inform your doctor if you notice any discomfort.
Is the use of Cancigin 50 Injection safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Cancigin. Immediately discontinue Cancigin if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Cancigin 50 Injection on the Kidneys?
There are no side effects of Cancigin on the kidneys.
What is the effect of Cancigin 50 Injection on the Liver?
Very few cases of side effects of Cancigin on the liver have been reported.
What is the effect of Cancigin 50 Injection on the Heart?
Cancigin is completely safe for the heart.
If you are suffering from any of the following diseases, you should not take Cancigin 50 Injection unless your doctor advises you to do so -
Is this Cancigin 50 Injection habit forming or addictive?
No, there is no any evidence that Cancigin 50 Injection is addictive.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Cancigin 50 Injection. So it is best to avoid driving.
Is it safe?
Yes, Cancigin 50 Injection is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, Cancigin 50 Injection cannot treat any kind of mental disorder.
Interaction between Food and Cancigin 50 Injection
Taking Cancigin 50 Injection with food does not harm your health.
Interaction between Alcohol and Cancigin 50 Injection
Information about the interaction of Cancigin 50 Injection and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 289-290
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 790
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Cancidas® (caspofungin acetate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Caspofungin Myx™ (caspofungin acetate)
